ID   UT-EC-2A
AC   CVCL_X004
SY   University of Turku-Endometrial Carcinoma-2A
DR   IARC_TP53; 21688
DR   Wikidata; Q54992043
RX   PubMed=7798295;
RX   PubMed=7821848;
RX   PubMed=8123477;
RX   PubMed=9887230;
CC   Doubling time: 40 hours (Note=At 17th passage) (PubMed=7821848).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=9887230).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C114656; Endometrial adenosquamous carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X005 ! UT-EC-2B
OI   CVCL_WM05 ! UT-EC-2C
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 11
//
RX   PubMed=7798295; DOI=10.1007/BF01194268;
RA   Rantanen V., Grenman S.E., Kulmala J., Alanen K., Lakkala T.,
RA   Grenman R.;
RT   "Sublethal damage repair after fractionated irradiation in endometrial
RT   cancer cell lines tested with the 96-well plate clonogenic assay.";
RL   J. Cancer Res. Clin. Oncol. 120:712-716(1994).
//
RX   PubMed=7821848; DOI=10.1006/gyno.1995.1009;
RA   Rantanen V., Grenman S.E., Kulmala J., Jaakkola M., Lakkala T.,
RA   Sajantila A., Klemi P., Grenman R.;
RT   "Characterization and radiosensitivity of UT-EC-2A and UT-EC-2B, two
RT   new highly radiosensitive endometrial cancer cell lines derived from a
RT   primary and metastatic tumor of the same patient.";
RL   Gynecol. Oncol. 56:53-62(1995).
//
RX   PubMed=8123477; DOI=10.1038/bjc.1994.87; PMCID=PMC1968845;
RA   Rantanen V., Grenman S.E., Kulmala J., Grenman R.;
RT   "Comparative evaluation of cisplatin and carboplatin sensitivity in
RT   endometrial adenocarcinoma cell lines.";
RL   Br. J. Cancer 69:482-486(1994).
//
RX   PubMed=9887230; DOI=10.1006/gyno.1998.5194;
RA   Rantanen V., Grenman S.E., Kurvinen K., Hietanen S.H., Raitanen M.,
RA   Syrjanen S.M.;
RT   "p53 mutations and presence of HPV DNA do not correlate with
RT   radiosensitivity of gynecological cancer cell lines.";
RL   Gynecol. Oncol. 71:352-358(1998).
//